{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T20:40:20Z","timestamp":1714941620159},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T00:00:00Z","timestamp":1360627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s11102-013-0469-1","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T09:03:38Z","timestamp":1360573418000},"page":"402-412","source":"Crossref","is-referenced-by-count":6,"title":["Pituitary disease mortality: is it fiction?"],"prefix":"10.1007","volume":"16","author":[{"given":"Eva Marie","family":"Erfurth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Siesj\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bj\u00f6rk-Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,12]]},"reference":[{"key":"469_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","volume":"336","author":"T Ros\u00e9n","year":"1990","unstructured":"Ros\u00e9n T, Bengtsson B\u00c5 (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285\u2013288","journal-title":"Lancet"},{"key":"469_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","volume":"46","author":"B B\u00fclow","year":"1997","unstructured":"B\u00fclow B, Hagmar L, Mikoczy Z, Nordstr\u00f6m CH, Erfurth EM (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 46:75\u201378","journal-title":"Clin Endocrinol"},{"key":"469_CR3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","volume":"357","author":"Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM West Midlands Prospective Hypopituitary Study Group","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM West Midlands Prospective Hypopituitary Study Group (2001) Association between premature mortality and hypopituitarism. Lancet 357:425\u2013431","journal-title":"Lancet"},{"issue":"5","key":"469_CR4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2265.2007.02947.x","volume":"67","author":"EH Nielsen","year":"2007","unstructured":"Nielsen EH, Lindholm J, Laurberg P (2007) Excess mortality in women with pituitary disease: a meta-analysis. Clin Endocrinol (Oxf) 67(5):693\u2013697","journal-title":"Clin Endocrinol (Oxf)"},{"key":"469_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-07-0013","volume":"157","author":"K Stochholm","year":"2007","unstructured":"Stochholm K, Gravholt CH, Laursen T, Laurberg P, Andersen M, Kristensen L\u00d8, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Green A (2007) Mortality and GH deficiency: a nationwide study. Eur J Endocrinol 157:9\u201318","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"469_CR6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.2002.01570.x","volume":"57","author":"M Brada","year":"2002","unstructured":"Brada M, Ashley S, Ford D, Traish D, Burchell L, Rajan B (2002) Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol 57(6):713\u2013717","journal-title":"Clin Endocrinol"},{"key":"469_CR7","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","volume":"89","author":"J Svensson","year":"2004","unstructured":"Svensson J, Bengtsson B\u00c5, Ros\u00e9n T, Od\u00e9n A, Johannsson G (2004) Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J Clin Endocrinol Metab 89:3306\u20133312","journal-title":"J Clin Endocrinol Metab"},{"key":"469_CR8","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1210\/jc.2002-020526","volume":"87","author":"EM Erfurth","year":"2002","unstructured":"Erfurth EM, Bulow B, Svahn-Tapper G, Norrving B, Odh K, Mikoczy Z, Bjork J, Hagmar L (2002) Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors. J Clin Endocrinol Metab 87:4892\u20134899","journal-title":"J Clin Endocrinol Metab"},{"key":"469_CR9","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1210\/jc.2003-030876","volume":"88","author":"E Barrett-Connor","year":"2003","unstructured":"Barrett-Connor E (2003) Clinical review 162: cardiovascular endocrinology 3: an epidemiologist looks at hormones and heart disease in women. J Clin Endocrinol Metab 88:4031\u20134042","journal-title":"J Clin Endocrinol Metab"},{"key":"469_CR10","unstructured":"Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O\u2019Sullivan MJ, Phillips L, Prentice RL (2004) Women\u2019s health initiative steering committee. JAMA 291(14):1701\u20131712"},{"key":"469_CR11","doi-asserted-by":"crossref","unstructured":"LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J; WHI Investigators (2011) Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 305(13):1305\u20131314","DOI":"10.1001\/jama.2011.382"},{"key":"469_CR12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00005344-198900131-00003","volume":"13","author":"WB Kannel","year":"1989","unstructured":"Kannel WB (1989) Risk factors in hypertension. J Cardiovasc Pharmacol 13:4\u201310","journal-title":"J Cardiovasc Pharmacol"},{"key":"469_CR13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0140-6736(90)90878-9","volume":"335","author":"S MacMahon","year":"1990","unstructured":"MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335:765\u2013777","journal-title":"Lancet"},{"key":"469_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/acta.0.1290195","volume":"129","author":"T Ros\u00e9n","year":"1993","unstructured":"Ros\u00e9n T, Ed\u00e9n S, Larson G, Wilhelmsen L, Bengtsson B\u00c5 (1993) Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:195\u2013200","journal-title":"Acta Endocrinol (Copenh)"},{"key":"469_CR15","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1172\/JCI119095","volume":"98","author":"RH Boger","year":"1996","unstructured":"Boger RH, Skamira C, Bode-Boger SM, Brabant G, von zur Muhlen A, Frolich JC (1996) Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Invest 98:2706\u20132713","journal-title":"J Clin Invest"},{"key":"469_CR16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2265.2002.01514.x","volume":"56","author":"JC Smith","year":"2002","unstructured":"Smith JC, Evans LM, Wilkinson I, Goodfellow J, Cockcroft JR, Scanlon MF, Davies JS (2002) Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study. Clin Endocrinol (Oxf) 56:493\u2013501","journal-title":"Clin Endocrinol (Oxf)"},{"key":"469_CR17","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","volume":"89","author":"P Maison","year":"2004","unstructured":"Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P, Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials (2004) Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials. J Clin Endocrinol Metab 89:2192\u20132199","journal-title":"J Clin Endocrinol Metab"},{"key":"469_CR18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.84.2.453","volume":"84","author":"M Pfeifer","year":"1999","unstructured":"Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P, Clayton RN (1999) Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 84:453\u2013457","journal-title":"J Clin Endocrinol Metab"},{"key":"469_CR19","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1210\/jc.87.8.3650","volume":"87","author":"A Colao","year":"2002","unstructured":"Colao A, Di Somma C, Salerno M, Spinelli L, Orio F, Lombardi G (2002) The cardiovascular risk of GH-deficient adolescents. J Clin Endocrinol Metab 87:3650\u20133655","journal-title":"J Clin Endocrinol Metab"},{"key":"469_CR20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/jc.84.4.1329","volume":"84","author":"F Borson-Chazot","year":"1999","unstructured":"Borson-Chazot F, Serusclat A, Kalfallah Y, Ducottet X, Sassolas G, Bernard S, Labrousse F, Pastene J, Sassolas A, Roux Y, Berthez\u00e8ne F (1999) Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. J Clin Endocrinol Metab 84:1329\u20131333","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"469_CR21","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine Society (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(6):1587\u20131609","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"469_CR22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/eje.1.02179","volume":"5","author":"R Abs","year":"2006","unstructured":"Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, G\u00f3th MI, Wilton P, Koltowska-H\u00e4ggstr\u00f6m M (2006) Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults\u2014a KIMS database analysis. Eur J Endocrinol 5(1):79\u201390","journal-title":"Eur J Endocrinol"},{"key":"469_CR23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","volume":"133","author":"G Sesmilo","year":"2000","unstructured":"Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A (2000) Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 133:111\u2013122","journal-title":"Ann Intern Med"},{"key":"469_CR24","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1210\/jc.87.5.2121","volume":"87","author":"J Svensson","year":"2002","unstructured":"Svensson J, Fowelin J, Landin K, Bengtsson B-\u00c5, Johansson J-O (2002) Effects of seven years of growth hormone (GH) replacement therapy on insulin sensitivity in GH deficient adults. J Clin Endocrinol Metab 87:2121\u20132127","journal-title":"J Clin Endocrinol Metab"},{"key":"469_CR25","doi-asserted-by":"crossref","unstructured":"B\u00fclow B, Erfurth EM (1999) A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance. Clin Endocrinol (Oxf) 50(1):45\u201355","DOI":"10.1046\/j.1365-2265.1999.00595.x"},{"issue":"6","key":"469_CR26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1530\/eje.0.1490511","volume":"9","author":"M Segerlantz","year":"2003","unstructured":"Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC (2003) Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults. Eur J Endocrinol 9(6):511\u2013519","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"469_CR27","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1210\/jc.2010-0117","volume":"95","author":"C Follin","year":"2010","unstructured":"Follin C, Thil\u00e9n U, Osterberg K, Bj\u00f6rk J, Erfurth EM (2010) Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab 95(8):3726\u20133735","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"469_CR28","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1210\/jc.2007-0458","volume":"92","author":"H Holmer","year":"2007","unstructured":"Holmer H, Svensson J, Rylander L, Johannsson G, Ros\u00e9n T, Bengtsson BA, Thor\u00e9n M, H\u00f6ybye C, Degerblad M, Bramnert M, H\u00e4gg E, Ed\u00e9n Engstr\u00f6m B, Ekman B, Norrving B, Hagmar L, Erfurth EM (2007) Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone. J Clin Endocrinol Metab 92(9):3560\u20133567","journal-title":"J Clin Endocrinol Metab"},{"key":"469_CR29","doi-asserted-by":"crossref","unstructured":"van Bunderen CC, van Nieuwpoort IC, Arwert LI, Heymans MW, Franken AA, Koppeschaar HP, van der Lely AJ, Drent ML (2011) Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch national registry of growth hormone treatment in adults. J Clin Endocrinol Metab 96(10):3151\u20133159","DOI":"10.1210\/jc.2011-1215"},{"key":"469_CR30","first-page":"115","volume":"35","author":"KK Ho","year":"2006","unstructured":"Ho KK, Gibney J, Johannsson G, Wolthers T (2006) Regulating of growth hormone sensitivity by sex steroids: implications for therapy. Front Horm Res 35:115\u2013128","journal-title":"Front Horm Res"},{"key":"469_CR31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jc.82.2.550","volume":"82","author":"P Burman","year":"1997","unstructured":"Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA (1997) Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82:550\u2013555","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"469_CR32","doi-asserted-by":"crossref","first-page":"E266","DOI":"10.1152\/ajpendo.00483.2004","volume":"289","author":"J Gibney","year":"2005","unstructured":"Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK (2005) Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 289(2):E266\u2013E271","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"469_CR33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/jcem-67-5-1111","volume":"67","author":"C Grunfeld","year":"1988","unstructured":"Grunfeld C, Sherman B, Cavalieri R (1988) The acute effects of human growth hormone administration on thyroid function in normal men. J Clin Endocrionol Metab 67:1111\u20131114","journal-title":"J Clin Endocrionol Metab"},{"issue":"5","key":"469_CR34","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jc.87.5.2042","volume":"87","author":"S Porretti","year":"2002","unstructured":"Porretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, Valle D, Arosio M, Beck-Peccoz P (2002) Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? J Clin Endocrinol Metab 87(5):2042\u20132045","journal-title":"J Clin Endocrinol Metab"},{"key":"469_CR35","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1210\/jcem-69-6-1127","volume":"69","author":"J J\u00f6rgensen","year":"1989","unstructured":"J\u00f6rgensen J, Pedersen A, Laurberg P (1989) Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central Hypothyroidism. J Clin Endocrinol Metab 69:1127\u20131132","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"469_CR36","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.2007.02763.x","volume":"66","author":"A Agha","year":"2007","unstructured":"Agha A, Monson JP (2007) Modulation of glucocorticoid metabolism by the growth hormone\u2014IGF-1 axis. Clin Endocrinol (Oxf) 66(4):459\u2013465","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"469_CR37","first-page":"263","volume":"46","author":"TA Howlett","year":"1997","unstructured":"Howlett TA (1997) An assessment of optimal hydrocortisone replacement therapy 46(3):263\u2013268","journal-title":"An assessment of optimal hydrocortisone replacement therapy"},{"key":"469_CR38","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"Filipsson H, Monson JP, Koltowska-H\u00e4ggstr\u00f6m M, Mattsson A, Johannsson G (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91:3954\u20133961","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"469_CR39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jc.2011-1926","volume":"97","author":"G Johannsson","year":"2012","unstructured":"Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engstr\u00f6m BE, Olsson T, Ragnarsson O, Ryberg M, Wahlberg J, Biller BM, Monson JP, Stewart PM, Lennern\u00e4s H, Skrtic S (2012) Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab 97(2):473\u2013481","journal-title":"J Clin Endocrinol Metab"},{"key":"469_CR40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.beem.2009.05.002","volume":"23","author":"M Buchfelder","year":"2009","unstructured":"Buchfelder M, Schlaffer S (2009) Surgical treatment of pituitary tumors. Best Pract Res Clin Endocrinol Metabol 23:677\u2013692","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"3","key":"469_CR41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/lary.22479","volume":"122","author":"TR DeKlotz","year":"2012","unstructured":"DeKlotz TR, Chia SH, Lu W, Makambi KH, Aulisi E, Deeb Z (2012) Meta-analysis of endoscopic versus sublabial pituitary surgery. Laryngoscope 122(3):511\u2013518","journal-title":"Laryngoscope"},{"key":"469_CR42","first-page":"175","volume":"40","author":"J Strychowsky","year":"2011","unstructured":"Strychowsky J, Nayan S, Reddy K, Farrokhyar F, Sommer D (2011) Purely endoscopic transsphenoidal surgery versus traditional microsurgery for resection of pituitary adenomas: systematic review. J Otolaryngol Head Neck Surg 40:175\u2013185","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"469_CR43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11102-008-0120-8","volume":"11","author":"M Buchfelder","year":"2008","unstructured":"Buchfelder M, Kreutzer J (2008) Transcranial surgery for pituitary adenomas. Pituitary 11:375\u2013384","journal-title":"Pituitary"},{"key":"469_CR44","doi-asserted-by":"crossref","unstructured":"Barzaghi LR, Losa M, Giovanelli M, Mortini P (2007) Complications of transsphenoidal surgery in patients with pituitary adenoma: experience at a single centre. Acta neurochirurgica 149:877\u2013885, discussion 885\u2013876","DOI":"10.1007\/s00701-007-1244-8"},{"key":"469_CR45","doi-asserted-by":"crossref","unstructured":"M\u00fcsl\u00fcman AM, Cansever T, Y\u0131lmaz A, Kanat A, Oba E, \u00c7avu\u015fo\u011flu H, Sirino\u011flu D, Ayd\u0131n Y. (2011) Surgical results of large and giant pituitary adenomas with special consideration of ophthalmologic outcomes. WNEU 76:141\u2013148, discussion 163\u2013146","DOI":"10.1016\/j.wneu.2011.02.009"},{"key":"469_CR46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/eje.1.01863","volume":"152","author":"P Nomikos","year":"2005","unstructured":"Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical cure. Eur J Endocrinol 152:379\u2013387","journal-title":"Eur J Endocrinol"},{"key":"469_CR47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/02688697.2011.591947","volume":"26","author":"NS Kurwale","year":"2012","unstructured":"Kurwale NS, Ahmad F, Suri A, Kale SS, Sharma BS, Mahapatra AK, Suri V, Sharma MC (2012) Post operative pituitary apoplexy: preoperative considerations toward preventing nightmare. Br J Neurosurg 26:59\u201363","journal-title":"Br J Neurosurg"},{"key":"469_CR48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/02688690903370305","volume":"24","author":"S Sinha","year":"2010","unstructured":"Sinha S, Sharma BS (2010) Giant pituitary adenomas\u2013an enigma revisited. Microsurgical treatment strategies and outcome in a series of 250 patients. Br J Neurosurg 24:31\u201339","journal-title":"Br J Neurosurg"},{"key":"469_CR49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3171\/2007.12.17635","volume":"111","author":"A Tabaee","year":"2009","unstructured":"Tabaee A, Anand VK, Barr\u00f3n Y, Hiltzik DH, Brown SM, Kacker A, Mazumdar M, Schwartz TH (2009) Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg 111:545\u2013554","journal-title":"J Neurosurg"},{"key":"469_CR50","doi-asserted-by":"crossref","unstructured":"Patil CG, Lad SP, Harsh GR, Laws E R, Boakye M (2007) National trends, complications, and outcomes following transsphenoidal surgery for Cushing\u2019s disease from 1993 to 2002. Neurosurg Focus 23:1\u20136","DOI":"10.3171\/foc.2007.23.3.9"},{"key":"469_CR51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1227\/NEU.0b013e3182535a00","volume":"71","author":"AS Puri","year":"2012","unstructured":"Puri AS, Zada G, Zarzour H, Laws E, Frerichs K (2012) Cerebral vasospasm after transsphenoidal resection of pituitary macroadenomas: report of 3 cases and review of the literature. Neurosurgery 71:173\u2013181","journal-title":"Neurosurgery"},{"key":"469_CR52","first-page":"655","volume":"18","author":"J Raymond","year":"1997","unstructured":"Raymond J, Hardy J, Czepko R, Roy D (1997) Arterial injuries in transsphenoidal surgery for pituitary adenoma; the role of angiography and endovascular treatment. AJNR 18:655\u2013665","journal-title":"AJNR"},{"key":"469_CR53","doi-asserted-by":"crossref","unstructured":"Ciric I, Ragin A, Baumgartner C, Pierce D (1997) Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225\u2013236, discussion 236\u2013227","DOI":"10.1097\/00041327-199712000-00044"},{"key":"469_CR54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11102-005-3280-9","volume":"8","author":"E Erturk","year":"2005","unstructured":"Erturk E, Tuncel E, Kiyici S, Ersoy C, Duran C, Imamoglu S (2005) Outcome of surgery for acromegaly performed by different surgeons: importance of surgical experience. Pituitary 8:93\u201397","journal-title":"Pituitary"},{"key":"469_CR55","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3171\/jns.1991.74.5.0695","volume":"74","author":"LN Sutton","year":"1991","unstructured":"Sutton LN, Gusnard D, Bruce DA, Fried A, Packer RJ, Zimmerman RA (1991) Fusiform dilatations of the carotid artery following radical surgery of childhood craniopharyngiomas. J Neurosurg 74:695\u2013700","journal-title":"J Neurosurg"},{"key":"469_CR56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11102-011-0308-1","volume":"14","author":"ME Sughrue","year":"2011","unstructured":"Sughrue ME, Chang EF, Gabriel RA, Aghi MK, Blevins LS (2011) Excess mortality for patients with residual disease following resection of pituitary adenomas. Pituitary 14:276\u2013283","journal-title":"Pituitary"},{"key":"469_CR57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archneur.1989.00520400109029","volume":"46","author":"KE Murros","year":"1989","unstructured":"Murros KE, Toole JF (1989) The effect of radiation on carotid arteries. Arch Neurol 46:449\u2013455","journal-title":"Arch Neurol"},{"key":"469_CR58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00006123-200001000-00026","volume":"46","author":"MM O\u2019Connor","year":"2000","unstructured":"O\u2019Connor MM, Mayberg MR (2000) Effects of radiation on cerebral vasculature: a review. Neurosurgery 46:138\u2013151","journal-title":"Neurosurgery"},{"key":"469_CR59","first-page":"181","volume":"7","author":"JW Hopewell","year":"1986","unstructured":"Hopewell JW, Campling D, Calvo W, Reinhold HS, Wilkinson JH, Yeung TK (1986) Vascular irradiation damage: its cellular basis and likely consequences. Br J Cancer 7:181\u2013191","journal-title":"Br J Cancer"},{"key":"469_CR60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2005.07.978","volume":"64","author":"BB Ronson","year":"2006","unstructured":"Ronson BB, Schulte RW, Han KP, Loredo LN, Slater JM, Slater JD (2006) Fractionated proton beam irradiation of pituitary adenomas. Int J Radiat Oncol Biol Phys 64:425\u2013434","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"469_CR61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00066-002-0826-x","volume":"178","author":"G Becker","year":"2002","unstructured":"Becker G, Kocher M, Kortmann RD, Paulsen F, Jeremic B, M\u00fcller RP, Bamberg M (2002) Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol 178(4):173\u2013186","journal-title":"Strahlenther Onkol"},{"key":"469_CR62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijrobp.2006.08.039","volume":"67","author":"HB Mackley","year":"2007","unstructured":"Mackley HB, Reddy CA, Lee SY, Harnisch GA, Mayberg MR, Hamrahian AH, Suh JH (2007) Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland clinic experience. Int J Radiat Oncol Biol Phys 67:232\u2013239","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"469_CR63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/01616412.1987.11739775","volume":"9","author":"DG Leksell","year":"1987","unstructured":"Leksell DG (1987) Stereotactic radiosurgery. Present status and future trends. Neurol Res 9(2):60\u201368","journal-title":"Neurol Res"},{"issue":"5","key":"469_CR64","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0360-3016(01)01535-8","volume":"50","author":"S Milker-Zabel","year":"2001","unstructured":"Milker-Zabel S, Debus J, Thilmann C, Schlegel W, Wannenmacher M (2001) Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 50(5):1279\u20131286","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"469_CR65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10143-007-0072-x","volume":"30","author":"G Minniti","year":"2007","unstructured":"Minniti G, Jaffrain-Rea ML, Osti M, Cantore G, Enrici RM (2007) Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques. Neurosurg Rev 30(3):167\u2013175","journal-title":"Neurosurg Rev"},{"key":"469_CR66","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/qjmed\/81.3.985","volume":"81","author":"M Littley","year":"1991","unstructured":"Littley M, Shalet S, Reid H (1991) The effect of external pituitary irradiation on elevated serum prolactin levels in patients with pituitary macroadenomas. Q J Med 81:985\u2013998","journal-title":"Q J Med"},{"key":"469_CR67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1227\/01.NEU.0000043709.53906.31","volume":"52","author":"V Vladyka","year":"2003","unstructured":"Vladyka V, Liscak R, Novotny J, Marek J, Jezkova J (2003) Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery 52:309\u2013317","journal-title":"Neurosurgery"},{"key":"469_CR68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11154-008-9106-0","volume":"10","author":"G Minniti","year":"2009","unstructured":"Minniti G, Gilbert DC, Brada M (2009) Modern techniques for pituitary radiotherapy. Rev Endocr Metab Disord 10:135\u2013144","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"469_CR69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.radonc.2012.04.024","volume":"104","author":"MG Sattler","year":"2012","unstructured":"Sattler MG, van Beek AP, Wolffenbuttel BH, van den Berg G, Sluiter WJ, Langendijk JA, van den Bergh AC (2012) The incidence of second tumors and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone. Radiother Oncol 104(1):125\u2013130","journal-title":"Radiother Oncol"},{"issue":"4","key":"469_CR70","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.2010.03947.x","volume":"74","author":"P Brummelman","year":"2011","unstructured":"Brummelman P, Elderson MF, Dullaart RP, van den Bergh AC, Timmer CA, van den Berg G, Koerts J, Tucha O, Wolffenbuttel BH, van Beek AP (2011) Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clin Endocrinol 74(4):481\u2013487","journal-title":"Clin Endocrinol"},{"issue":"2","key":"469_CR71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/EJE-11-0749","volume":"166","author":"P Brummelman","year":"2012","unstructured":"Brummelman P, Sattler MG, Meiners LC, Elderson MF, Dullaart RP, van den Berg G, Koerts J, Tucha O, Wolffenbuttel BH, van den Bergh AC, van Beek AP (2012) Cognitive performance after postoperative pituitary radiotherapy: a dosimetric study of the hippocampus and the prefrontal cortex. Eur J Endocrinol 166(2):171\u2013179","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"469_CR72","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2265.2011.04300.x","volume":"76","author":"J Ayuk","year":"2012","unstructured":"Ayuk J (2012) Does pituitary radiotherapy increase the risk of stroke and, if so, what preventative actions should be taken? Clin Endocrinol 76(3):328\u2013331","journal-title":"Clin Endocrinol"},{"issue":"11","key":"469_CR73","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","volume":"94","author":"M Sherlock","year":"2009","unstructured":"Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM (2009) ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 94(11):4216\u20134223","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-013-0469-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-013-0469-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-013-0469-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T20:02:32Z","timestamp":1714939352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-013-0469-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,12]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1007\/s11102-013-0469-1","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,12]]}}}